Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Maze Therapeutics (MAZE) Net Margin (2024)

Maze Therapeutics has reported Net Margin over the past 1 years, most recently at 990.08% for Q3 2024.

  • Quarterly Net Margin changed N/A to 990.08% in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 3873.72% through Jun 2025, changed N/A year-over-year, with the annual reading at 2.03% for FY2024, N/A changed from the prior year.
  • Net Margin was 990.08% for Q3 2024 at Maze Therapeutics, down from 92.56% in the prior quarter.
  • Over five years, Net Margin peaked at 92.56% in Q2 2024 and troughed at 990.08% in Q3 2024.